Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

1. Megías-Vericat, J.E.
2. Bonanad, S.
3. Haya, S.
4. Cid, A.R.
5. Marqués, M.R.
6. Ferrada, A.
7. Monte-Boquet, E.
8. Pérez-Alenda, S.
9. Bosch, P.
10. Querol-Giner, F.
11. Poveda, J.L.